人类疾病中的细胞外囊泡和微生物群之间的相互作用:新的治疗机会
Rongjin Luo1,2, Yanmin Chang3, Huaizhen Liang1
1Department of Orthopaedics, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China.
iMeta
|June 13, 2024
概括
细菌细胞外囊泡 (BEVs) 是宿主微生物通信的关键媒介,影响各种疾病. 本综述探讨了BEV功能及其在诊断和治疗方面的潜力.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 微生物群的稳态对于宿主健康至关重要,细胞外囊泡 (EVs) 调解微生物群与宿主之间的通信.
- 细菌EV (BEV) 携带各种生物分子,并在生理和病理过程中发挥作用.
- BEVs与各种疾病有关,包括胃肠道,呼吸系统,神经系统和癌症.
研究的目的:
- 审查细菌EV (BEV) 生物发生,组成和生物功能的最新进展.
- 探索BEVs在疾病发病过程中的参与.
- 引入BEV在诊断和治疗方面的现有和新兴临床应用.
主要方法:
- 关于细菌EVs的最近研究的文献综述.
- 对BEV组成,生物发生和功能研究的分析.
- 综合关于BEV在疾病和临床应用中的作用的信息.
主要成果:
- BEVs是宿主微生物相互作用的多功能调解者.
- BEVs参与了许多疾病的发病.
- 基于BEV的平台显示出对诊断和治疗的前景.
结论:
- 了解BEV生物学对于破译宿主微生物相互作用和疾病机制至关重要.
- BEVs代表了开发新型诊断和治疗策略的有希望的途径.
- 对BEV的进一步研究将促进生物医学应用.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Surface Membrane Barriers
1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K
Intralumenal Vesicles and Multivesicular Bodies
3.4K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.4K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Receptor-mediated Endocytosis
6.1K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
6.1K


